Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Fulgent Genetics, Inc. (FLGT) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$83.34M |
|
$-23.42M |
|
$50.75M |
|
$32.58M |
|
$119.57M |
|
$-36.24M |
|
$6.96M |
|
$-29.27M |
|
$-29.27M |
|
$-23.65M |
|
$-23.65M |
|
$-23.65M |
|
$-23.65M |
|
$-36.24M |
|
-- |
|
30.98M |
|
30.98M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$790.11M |
|
$112.55M |
|
$423.42M |
|
$1.21B |
|
$106.81M |
|
-- |
|
-- |
|
$106.81M |
|
-- |
|
$1.11B |
|
$1.11B |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|